Skip to content
KStart free
AI InfrastructureDefenseQuantumAll studies →

MBRX US Equity

Moleculin Biotech, Inc.Health Care · Pharmaceutical Preparations · CIK 1659617 · FY ends Dec 31
$0.57
-0.04 (-6.24%)
USD · as of 2026-08-19 · marketstack
3 8-K filings · 0 13D · 2 13G
DateEventWhat happened / filerSource
2026-08-148-K 2.02Results of operations and financial condition (earnings)earnings history (EARN) →sec.gov ↗
2026-08-1013GSchedule 13G filed — ≥5% beneficial owner (passive) · by CVI Investments, Inc.sec.gov ↗
2026-08-0613GSchedule 13G filed — ≥5% beneficial owner (passive) · by INTRACOASTAL CAPITAL, LLCsec.gov ↗
2026-08-038-K 1.01Entry into a material definitive agreementsec.gov ↗
2026-07-318-K 7.01Regulation FD disclosuresec.gov ↗
Source: SEC EDGAR (public domain) · history starts 2026-07-31

Every row is a filed document, checked against its EDGAR index.